Autolus Therapeutics Presents Clinical Data Updates at the European Hematology Association Congress - AUTO4 shows high level of clinical activity with a novel targeting approach for patients with T Cell Lymphoma- AUTO1/22 demonstrates encouraging and durable responses in children ineligible for...